Cytomegalovirus pneumonia after human marrow transplantation.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 234706)

Published in Ann Intern Med on February 01, 1975

Authors

J D Myers, H C Spencer, J C Watts, M B Gregg, J A Stewart, R H Troupin, E D Thomas

Articles citing this

Antibodies to cytomegalovirus in homosexual and heterosexual men attending an STD clinic. Br J Vener Dis (1984) 1.70

Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol (1988) 1.57

Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother (1993) 1.51

Improved indirect hemagglutination test for cytomegalovirus using human O erythrocytes in lysine. J Clin Microbiol (1979) 1.47

Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect Immun (1978) 1.34

Pathogenesis of reactivated latent murine cytomegalovirus infection. Am J Pathol (1979) 1.28

Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation. J Exp Med (1981) 1.21

Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro. Antimicrob Agents Chemother (1980) 1.14

Mechanisms of virus-induced immune suppression. Can Med Assoc J (1985) 1.14

Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents. Antimicrob Agents Chemother (1983) 1.14

Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans. Infect Immun (1978) 1.13

Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells. J Virol (1998) 1.05

Chemiluminescent immunoenzymatic assay for rapid diagnosis of viral infections. J Clin Microbiol (1982) 0.94

Anticomplement immunofluorescence test that uses isolated fibroblast nuclei for detection of antibodies to human cytomegalovirus. J Clin Microbiol (1980) 0.91

Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. Am J Pathol (1980) 0.90

Herpesviruses. J Clin Pathol (1979) 0.89

Human immune responses to major human cytomegalovirus glycoprotein complexes. J Virol (1988) 0.88

Comparison of monoclonal and polyclonal antibody for confirmation of cytomegalovirus isolates by fluorescent staining. J Clin Microbiol (1984) 0.85

Susceptibility of clinical isolates of cytomegalovirus to human interferon. Antimicrob Agents Chemother (1977) 0.83

Cytomegalovirus infection in pediatric rheumatic diseases: a review. Pediatr Rheumatol Online J (2010) 0.81

Inhibition of human cytomegalovirus by trifluorothymidine. Antimicrob Agents Chemother (1983) 0.80

Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins. J Virol (2015) 0.78

Inhibition of human cytomegalovirus by combined acyclovir and vidarabine. Antimicrob Agents Chemother (1985) 0.77

Fatal cytomegalovirus infection after renal transplantation. Br Med J (1978) 0.75

Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients. Antimicrob Agents Chemother (1983) 0.75

Chronic cough in infants younger than three months. West J Med (1982) 0.75

Articles by these authors

(truncated to the top 100)

1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91

Internist-1, an experimental computer-based diagnostic consultant for general internal medicine. N Engl J Med (1982) 10.87

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64

Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54

Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61

Pontiac fever. An epidemic of unknown etiology in a health department: I. Clinical and epidemiologic aspects. Am J Epidemiol (1978) 5.54

Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11

A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01

Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89

Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59

Amebiasis: epidemiologic studies in the United States, 1971-1974. Ann Intern Med (1978) 3.58

The INTERNIST-1/QUICK MEDICAL REFERENCE project--status report. West J Med (1986) 3.53

Quick medical reference (QMR) for diagnostic assistance. MD Comput (1986) 3.43

Current concepts in parasitology. Amebiasis. N Engl J Med (1978) 3.41

Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40

Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31

Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22

Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03

Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95

Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89

Effects of fear and instructions on how to cope with danger. J Pers Soc Psychol (1967) 2.84

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75

Secondary transfer of intensive care patients by helicopter. Anaesthesia (2001) 2.67

Recovery from rabies. A case report. Ann Intern Med (1972) 2.65

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61

Midazolam for treatment of postoperative nausea. Anaesthesia (2001) 2.55

Nobel laureates' letter to President Bush. Washington Post (2001) 2.43

The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43

Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39

One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36

Giardiasis in American travelers to the Soviet Union. J Infect Dis (1974) 2.36

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29

Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28

Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24

Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23

Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med (2006) 2.15

Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13

A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06

Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04

Sensitivity of Plasmodium falciparum isolates to chloroquine in Kisumu and Malindi, Kenya. Am J Trop Med Hyg (1982) 2.04

Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature (1987) 2.04

Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99

Antiviral agents. 2. Structure-activity relationships of compounds related to 1-adamantanamine. J Med Chem (1971) 1.99

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98

A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil. J Pharm Pharmacol (1987) 1.95

Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94

Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: prognostic significance of detection method. Radiology (1993) 1.92

Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89

The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology (1980) 1.88

Epidemic viral hepatitis, type B, in hospital personnel. Am J Med (1974) 1.87

Influenza surveillance in the United States 1972-1974. Am J Epidemiol (1975) 1.86

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83

Technique for human marrow grafting. Blood (1970) 1.83

Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79

Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77

Pontiac fever: isolation of the etiologic agent (Legionella pneumophilia) and demonstration of its mode of transmission. Am J Epidemiol (1981) 1.77

Allogeneic marrow grafting for treatment of aplastic anemia. Blood (1974) 1.76

Diagnostic criteria for influenza B-associated Reye's syndrome: clinical vs. pathologic criteria. Pediatrics (1977) 1.75

A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75

Bone marrow grafts and tolerance. Nature (1986) 1.74

Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72

Marrow transplantation for thalassaemia. Lancet (1982) 1.71

Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70

How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70

Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool. J Clin Microbiol (1991) 1.70

Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. Blood (1998) 1.69

Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68

Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol (1996) 1.65

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64

Infectious diseases and injuries in child day care. Opportunities for healthier children. JAMA (1992) 1.64

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood (1987) 1.63

Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet (1984) 1.61

Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60

Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60

Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation (1974) 1.58

The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol (1977) 1.58

Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57

Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57

Hemophilia: role of organ homografts. Science (1969) 1.56

Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med (1981) 1.56

Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol (1979) 1.55

Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55

Vaccine-associated poliomyelitis in the United States, 1961-1972. Am J Epidemiol (1976) 1.54

INTERNIST-I properties: representing common sense and good medical practice in a computerized medical knowledge base. Comput Biomed Res (1985) 1.53

Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50

Inner volume MR imaging: technical concepts and their application. Radiology (1985) 1.50